FdaApplication
NDA 202515
Identifiers
- fda_app_no: NDA202515
Properties
| Property | Value |
|---|---|
| applicant_name | HOSPIRA INC |
| application_type | NDA |
| approval_date | 2011-11-14 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MORPHINE SULFATE | MORPHINE SULFATE | 50MG/ML | INJECTABLE;INJECTION |
| MORPHINE SULFATE | MORPHINE SULFATE | 4MG/ML | INJECTABLE;INJECTION |
| MORPHINE SULFATE | MORPHINE SULFATE | 10MG/ML | INJECTABLE;INJECTION |
| MORPHINE SULFATE | MORPHINE SULFATE | 2MG/ML | INJECTABLE;INJECTION |
| MORPHINE SULFATE | MORPHINE SULFATE | 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| MORPHINE SULFATE | MORPHINE SULFATE | 8MG/ML | INJECTABLE;INJECTION |
6 products